Navigation Links
Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
Date:6/16/2011

PARIS, June 16, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it has entered into a two-year research collaboration with the biopharmaceutical company Audion Therapeutics (Audion) to develop potential treatments for hearing loss through the optimization of small molecules by using a regenerative medicine approach.

(Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO)

This collaborative research will utilize technology developed at the Massachusetts Eye and Ear Infirmary in the Eaton-Peabody Laboratory, one of the world's largest basic research facilities dedicated to the study of hearing and deafness, by investigator and Audion co-founder Dr. Albert Edge, who has strong expertise in stem cells and inner ear biology. Audion licensed Dr. Edge's technology from Mass Eye and Ear. Under the terms of the agreement, Sanofi has an option to license technology rights from Audion related to research conducted under the collaboration.

"We are very excited about this collaboration with Sanofi that validates our thinking around developing small molecule regenerative drugs for the treatment of hearing loss," said RolfJan Rutten and Helmuth van Es, founders of Audion Therapeutics. "Sanofi's interest in the hearing loss field plus its vast experience and infrastructure in small-molecule drug discovery make them the perfect partner to move this program forward as diligently as possible."

"Our new relationship with Audion demonstrates our commitment to work with partners on conditions with unmet and growing medical needs, such as hearing loss," said Elias Zerhouni, M.D., President, Global Research & Development, Sanofi.  "This collaboration is a multi-disciplinary approach with our internal Aging Therapeutic Strategic Unit and our Early-to-Candidate Unit working together to
'/>"/>

SOURCE Sanofi
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims
2. sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
3. Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
4. Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research
5. Sanofi-Aventis Completes Acquisition of Genzyme Corporation
6. Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
7. Navinta LLC is Pleased to Announce US FDA Approval of Sodium Ferric Gluconate Injection in Sucrose [a generic equivalent of Ferrlecit® Injection by Sanofi Aventis] Based on Its Proprietary Technology
8. Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective
9. Sanofi-aventis Enters Into Research Collaboration With Columbia University to Develop New Diabetes Treatments
10. Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
11. Sanofi-Aventis Announces Approval and Closing of BMP Sunstone Acquisition Creating a Strong Consumer Health Care Platform in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Resources Group finds that the market for colorectal cancer (CRC) ... in the United States , ... Italy , Spain , the ... . The biosimilar erosion of Roche/Genentech/Chugai,s Avastin and Bristol-Myers Squibb/Eli ... of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s Lonsurf, Alchemia,s HA-irinotecan and ...
(Date:8/28/2014)... , Aug. 28, 2014 Levi & ... commenced in the United States District Court for the ... of investors who purchased Galectin Therapeutics Inc. ("Galectin" or ... and July 28, 2014. For more information, ... alleges that during the Class Period the Company violated ...
(Date:8/28/2014)... -- Nonin Medical, Inc., the inventor of finger pulse ... announced that the Food and Drug Administration (FDA) has ... for use in the United States ... hub or kiosk through a USB connector and measures ... patients. The Model 3231 received EU certification last year. ...
Breaking Medicine Technology:The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... Also Receives Patent Covering ARIKACE for Once-Daily Treatment of ... June 25 Cystic Fibrosis Foundation Therapeutics Inc., the ... a $2.2 million award to Transave Inc., for the ... antibiotic that aims to treat Pseudomonas lung ...
... , Study shows 4% CHG antiseptic is effective against a ... Ga., June 24 Hand washing with a 4% chlorhexidine ... to stop the spread of the H1N1 Swine Flu Virus. ... Personnel Hand Antiseptic Towelettes have been tested and found to ...
Cached Medicine Technology:Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 2Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 3Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 4Hand Washing with 4% CHG Antiseptic Kills Flu Viruses 2
(Date:8/29/2014)... 2014 Sansego is an ... interactive online community, and a range of personalized coaching ... the way to professional athletes. Crowie has brought together ... with him throughout the majority of his triathlon career. ... the triathlon public. , Sansego provides the following:, ...
(Date:8/29/2014)... RBS Reputation Management has brought a new ... service is to help those individuals and organizations that are ... Book. The service would push down the ranking of Scam ... fully invisible on Google. , RBS Reputation Management provides ... asked how company can provide guarantee of results with the ...
(Date:8/29/2014)... "After reading a study that said mortality ... I decided that there needed to be a way to ... a concerned inventor from Sikestons, Mo. , The Stand provides ... builds endurance and keeps the user from sitting too much. ... and producible in design variations, it's ideal for anyone who ...
(Date:8/29/2014)... basic life support (BLS) videos available on YouTube ... guidelines, according to a new study published in ... the Australasian College for Emergency Medicine (ACEM). ... arrest are known to improve survival for,victims. , ... together the study, which reviewed educational videos from ...
(Date:8/29/2014)... The Fresh Diet, America’s premier gourmet ... Fresh Vegetarian meal plan. Originating from The Fresh Diet’s ... menu is designed to satisfy customers seeking a convenient, ... , Responding to the growing demand by customers for ... market (Forbes) with 14% of Americans identifying vegetarian meals ...
Breaking Medicine News(10 mins):Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 2Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 3Health News:RBS Reputation Management Announces a New Online Reputation Management Service 2Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 2Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 3
... Watson Pharmaceuticals, Inc., a,leading specialty pharmaceutical company, ... Transdermal System patches sold in the United States ... recalled,patches are from Lot Number 92461850, have expiration ... Watson Laboratories, Inc. The affected lot of,Fentanyl Transdermal ...
... Aug. 8 The Health Resources,and Services Administration ... center grants to help people in need -- ... the comprehensive primary and preventive,health care services that ... care," said HRSA Administrator,Elizabeth Duke. "These awards will ...
... Aug. 8 MedQuist,Inc.,(Nasdaq: MEDQ ) the largest ... its results for the quarter ended June,30, 2008. Revenue ... compared,with $88.7 million in the second quarter of 2007. ... the prior year period was primarily due to,customer losses ...
... and drug addiction are polar opposite diseases, but both ... have enough of it; drug addicts get too much ... disorders has been well known, the way it works ... University,s Feinberg School of Medicine has revealed that dopamine ...
... cut behind uterus and into woman,s body cavity , , ... say may be the first operation of its kind ... University Medical Center removed a woman,s gallbladder without making ... part of an ongoing clinical research trial, involved insertion ...
... Receive $15 ... ... Mercy Health Plan, the,largest medical assistance care organization in Pennsylvania, ... that provides community-based, primary medical,dental and behavioral health care services, ...
Cached Medicine News:Health News:Watson Announces Limited Recall of Fentanyl Transdermal System 2Health News:Watson Announces Limited Recall of Fentanyl Transdermal System 3Health News:MedQuist Reports Second Quarter 2008 Results 2Health News:MedQuist Reports Second Quarter 2008 Results 3Health News:MedQuist Reports Second Quarter 2008 Results 4Health News:MedQuist Reports Second Quarter 2008 Results 5Health News:MedQuist Reports Second Quarter 2008 Results 6Health News:MedQuist Reports Second Quarter 2008 Results 7Health News:MedQuist Reports Second Quarter 2008 Results 8Health News:MedQuist Reports Second Quarter 2008 Results 9Health News:Why dopamine freezes parkinson patients and drives drug addicts 2Health News:Why dopamine freezes parkinson patients and drives drug addicts 3Health News:New Technique Removes Gallbladder Without External Incisions 2Health News:Keystone Mercy and DVCH to Offer Screenings for National Health Center Week 2
... 500 Power Supply is designed ... offers extensive programming capabilities, including ... methods for you to set ... simple, intuitive PowerEase® interface is ...
... The PowerEase® 500 Power ... mini-gel electrophoresis. It offers extensive ... and four custom methods for ... own preferences. The simple intuitive ...
... These modified battery chargers ... supplies for GENIE blotters. ... produce very specific voltages, ... than laboratory power supplies. ...
PS2A200 Power supply is a high current power supply ideal for all types of electrophoresis blotting and short electrophoresis runs....
Medicine Products: